We are live on ! Find out more
ONCE

Spark Therapeutics, Inc. Common Stock
ONCE

Delisted

ONCE was delisted on the 16th of December, 2019.

Back to rankings

160 hedge funds and large institutions have $1.92B invested in Spark Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 61 increasing their positions, 33 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more call options, than puts

Call options by funds: $33.3M | Put options by funds: $17.5M

85% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 33

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

6% less first-time investments, than exits

New positions opened: 44 | Existing positions closed: 47

2% less funds holding

Funds holding: 163 → 160 (-3)

39% less capital invested

Capital invested by funds: $3.15B → $1.92B (-$1.23B)

Holders
160
Holders Change
-3
Holders Change %
-1.84%
% of All Funds
3.63%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
44
Increased
61
Reduced
33
Closed
47
Calls
$33.3M
Puts
$17.5M
Net Calls
+$15.8M
Net Calls Change
+$18.4M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$161M
2
GGHC
Gilder Gagnon Howe & Co
New York
+$39.4M
3
GPP
Great Point Partners
Connecticut
+$29.5M
4
JP Morgan Chase
JP Morgan Chase
New York
+$28.1M
5
RFS
Rockefeller Financial Services
New York
+$25.3M

Top Sellers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$55.1M
2
Deutsche Bank
Deutsche Bank
Germany
-$54.9M
3
O
OrbiMed
New York
-$38.3M
4
LCM
Laurion Capital Management
New York
-$34.7M
5
Jennison Associates
Jennison Associates
New York
-$27.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
51
TIAA CREF Investment Management
New York
$3.85M -$295K -4,105 -5%
RPAM
52
Rhenman & Partners Asset Management
Sweden
$3.61M +$5.04M +70,200 New
HT
53
HAP Trading
New York
$3.43M +$4.79M +66,660 New
AllianceBernstein
54
AllianceBernstein
Tennessee
$3.42M -$14.4K -200 -0.3%
GC
55
Guggenheim Capital
Illinois
$3.3M +$921K +12,823 +25%
Citigroup
56
Citigroup
New York
$3.28M +$1.96M +27,307 +75%
Principal Financial Group
57
Principal Financial Group
Iowa
$3.2M +$580K +8,073 +15%
Balyasny Asset Management
58
Balyasny Asset Management
Illinois
$2.99M -$5.15M -71,703 -55%
B
59
Bailard
California
$2.84M +$1.05M +14,555 +36%
UBS Group
60
UBS Group
Switzerland
$2.79M -$1.66M -23,046 -30%
TA
61
Teachers Advisors
New York
$2.76M +$385K +5,356 +11%
SGA
62
Sector Gamma AS
Norway
$2.7M +$3.77M +52,500 New
New York State Common Retirement Fund
63
New York State Common Retirement Fund
New York
$2.66M +$1.92M +26,787 +108%
Swiss National Bank
64
Swiss National Bank
Switzerland
$2.64M – – –
CWG
65
C WorldWide Group
Denmark
$2.47M -$309K -4,298 -8%
California State Teachers Retirement System (CalSTRS)
66
California State Teachers Retirement System (CalSTRS)
California
$2.24M +$61.1K +851 +2%
TAM
67
Tocqueville Asset Management
New York
$2.17M -$122K -1,700 -4%
California Public Employees Retirement System
68
California Public Employees Retirement System
California
$2.13M +$115K +1,600 +4%
AA
69
ALPS Advisors
Colorado
$2.08M +$375K +5,215 +15%
TCM
70
Tekla Capital Management
Massachusetts
$1.99M +$1.03M +14,406 +59%
MOACM
71
Mutual of America Capital Management
New York
$1.97M +$2.76M +38,396 New
UONDDL
72
University of Notre Dame du Lac
Indiana
$1.97M +$2.76M +38,371 New
D.E. Shaw & Co
73
D.E. Shaw & Co
New York
$1.92M -$246K -3,431 -8%
CG
74
Cutler Group
California
$1.86M +$2.6M +36,202 New
SG Americas Securities
75
SG Americas Securities
New York
$1.68M +$1.11M +15,493 +91%
1 2
3
4 5

ONCE Hedge Fund Activity: Q4 2017 in Review

160 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Spark Therapeutics, Inc. Common Stock (ONCE) for Q4 2017, worth a combined $1.92B — down 39% from $3.15B a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of ONCE and 44 opened new positions — a net loss of 3 holders — while 33 trimmed existing stakes and 61 added.

The largest buyer was Wellington Management Group, adding an estimated $161M. The largest seller was Lord, Abbett & Co, cutting an estimated $55.1M.

  • 160 institutional investors held Spark Therapeutics, Inc. Common Stock (ONCE) as of Q4 2017, down from 163 in Q3 2017.
  • Funds reported $1.92B of Spark Therapeutics, Inc. Common Stock stock for Q4 2017, down 39% quarter-over-quarter.
  • 44 funds opened new Spark Therapeutics, Inc. Common Stock positions in Q4 2017 and 47 closed out, a net change of -3 holders.
  • The largest Spark Therapeutics, Inc. Common Stock buyer in Q4 2017 was Wellington Management Group, an estimated $161M added.
  • The largest Spark Therapeutics, Inc. Common Stock seller in Q4 2017 was Lord, Abbett & Co, an estimated $55.1M sold.

Based on aggregated 13F filings for Q4 2017.